Compounds > esonarimod
Page last updated: 2024-09-03

esonarimod and penicillamine

esonarimod has been researched along with penicillamine in 3 studies

Compound Research Comparison

Studies
(esonarimod)		Trials
(esonarimod)		Recent Studies (post-2010)
(esonarimod)		Studies
(penicillamine)		Trials
(penicillamine)		Recent Studies (post-2010) (penicillamine)
33187,415312442

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, M; Iwabuchi, H; Kasahara, K; Kasama, T; Katsura, T; Kobayashi, K; Sugihara, S; Takahashi, T; Takeshita, K; Yamagata, N1
Fukushima, K; Inoue, T; Takeshita, K1
Inoue, T; Nakaike, S; Sugimoto, M; Takeshita, K; Yamashita, M1

Other Studies

3 other study(ies) available for esonarimod and penicillamine

ArticleYear
Suppression of pulmonary granulomatous inflammation by immunomodulating agents.
    Agents and actions, 1992, Volume: 37, Issue:1-2

    Topics: Animals; Cytokines; Dexamethasone; Female; Granuloma, Foreign-Body; Interleukin-1; Lung Diseases; Mice; Mice, Inbred BALB C; Penicillamine; Phenylpropionates

1992
Effects of KE-758; an active metabolite of the new anti-rheumatic drug KE-298, D-penicillamine, bucillamine and auranofin on the proliferation of murine lymphocytes, and the production of nitric oxide by murine macrophages.
    International immunopharmacology, 2001, Volume: 1, Issue:5

    Topics: Animals; Antirheumatic Agents; Auranofin; Cell Division; Cell Line; Concanavalin A; Cysteine; Female; Hydrogen Peroxide; In Vitro Techniques; Interferon-gamma; Ionomycin; Lipopolysaccharides; Lymphocyte Activation; Lymphocytes; Macrophages; Mice; Mice, Inbred DBA; Nitric Oxide; Penicillamine; Phenylpropionates; Recombinant Proteins; Tetradecanoylphorbol Acetate

2001
KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line.
    Drugs under experimental and clinical research, 2002, Volume: 28, Issue:5

    Topics: Antirheumatic Agents; Auranofin; Cell Line; Cysteine; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Monocytes; Penicillamine; Phenylbutyrates; Phenylpropionates; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha

2002